Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02000167 · ClinicalTrials.gov registry record
Mitochondrial Dysfunction in Phelan-McDermid Syndrome
A clinical trial of Phelan-McDermid Syndrome, sponsored by University of Arkansas.
- Completed
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT02000167 is a study of Phelan-McDermid Syndrome that has completed, run by University of Arkansas. The registered enrollment target is 51 participants, below the 99-participant average among 4 other Phelan-McDermid Syndrome trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02000167, a study of Phelan-McDermid Syndrome, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a relationship exists between gene deletion(s) specific to the mitochondrial electron transport chain and presentation of clinical characteristics in patients with Phelan-McDermid Syndrome (PMS).
Conditions Studied
Study Locations (1)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02000167
The ClinicalTrials.gov registry entry for NCT02000167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 4 other Phelan-McDermid Syndrome trials with a reported enrollment target (48% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Phelan-McDermid Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02000167 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT02000167 about?
NCT02000167 is a clinical study titled "Mitochondrial Dysfunction in Phelan-McDermid Syndrome". The purpose of this study is to determine whether a relationship exists between gene deletion(s) specific to the mitochondrial electron transport chain and presentation of clinical characteristics in patients with Phelan-McDermid Syndrome (PMS).
What is the current status of trial NCT02000167?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2012-05. Estimated completion is 2015-05.
What conditions does trial NCT02000167 study?
This clinical trial studies the following conditions: Phelan-McDermid Syndrome.
Who is sponsoring clinical trial NCT02000167?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02000167 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phelan-McDermid Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency
RECRUITING · Phase 1
-
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
RECRUITING · Phase 3
-
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
ACTIVE NOT RECRUITING
-
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.